<DOC>
	<DOCNO>NCT01675375</DOCNO>
	<brief_summary>The purpose research determine investigational thin shield effectively reduce discomfort follow Laser Vision Correction .</brief_summary>
	<brief_title>Laser Vision Correction Use Eye Shield Maintaining Vision Mitigating Pain</brief_title>
	<detailed_description />
	<criteria>Patients schedule undergo Laser Vision Correction correction refractive error FDA approve treatment guideline Laser Vision Correction Age 1860 Patients able understand requirement study , willing follow study instruction , provide write informed consent participate , comply study requirement , include require study followup visit Any anterior segment abnormality associate LAser Vision Correction Any abnormality associate eye lid Uncontrolled blepharitis dry eye Prior laser treatment retina Any ophthalmic surgery perform within three ( 3 ) month prior study exclude PRK LASIK Diagnosis glaucoma Active diabetic retinopathy Clinically significant inflammation infection within six ( 6 ) month prior study Uncontrolled systemic disease ( e.g. , diabetes , hypertension , etc . ) opinion Investigator Participation study involve investigational drug within past 30 calendar day , ongoing participation study investigational material Intolerance hypersensitivity topical anesthetic , antibiotic , steroid pharmaceutical may use pre post surgically Specifically know intolerance hypersensitivity contact lenses component investigative material A medical condition , serious concurrent illness , extenuate circumstance would significantly decrease study compliance , include prescribed followup Any condition , opinion investigator , would jeopardize safety patient Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>